Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$0.42 - $0.72 $12,838 - $22,009
-30,569 Reduced 70.73%
12,651 $7,000
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $156 - $399
-261 Reduced 0.6%
43,220 $25,000
Q2 2023

Aug 09, 2023

SELL
$1.05 - $1.63 $7,035 - $10,921
-6,700 Reduced 13.35%
43,481 $49,000
Q1 2023

May 17, 2023

SELL
$1.2 - $2.73 $4,800 - $10,920
-4,000 Reduced 7.38%
50,181 $67,000
Q4 2022

Feb 13, 2023

SELL
$1.71 - $3.61 $9,784 - $20,656
-5,722 Reduced 9.55%
54,181 $100,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $49,204 - $223,491
25,897 Added 76.15%
59,903 $147,000
Q2 2022

Aug 02, 2022

SELL
$2.13 - $9.01 $967 - $4,090
-454 Reduced 1.32%
34,006 $83,000
Q1 2022

May 23, 2022

BUY
$6.28 - $15.59 $55,697 - $138,267
8,869 Added 34.66%
34,460 $275,000
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $287,017 - $559,781
-19,525 Reduced 43.28%
25,591 $391,000
Q3 2021

Nov 05, 2021

SELL
$24.31 - $33.6 $14,148 - $19,555
-582 Reduced 1.27%
45,116 $1.28 Million
Q2 2021

Aug 12, 2021

BUY
$26.09 - $40.4 $45,683 - $70,740
1,751 Added 3.98%
45,698 $1.54 Million
Q1 2021

May 24, 2021

BUY
$33.06 - $56.93 $597,592 - $1.03 Million
18,076 Added 69.87%
43,947 $1.68 Million
Q4 2020

Feb 09, 2021

BUY
$39.09 - $57.4 $734,344 - $1.08 Million
18,786 Added 265.15%
25,871 $1.08 Million
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $92,823 - $145,847
-3,265 Reduced 31.55%
7,085 $307,000
Q2 2020

Aug 10, 2020

BUY
$11.71 - $30.29 $9,368 - $24,232
800 Added 8.38%
10,350 $314,000
Q1 2020

May 15, 2020

BUY
$7.64 - $27.5 $10,696 - $38,500
1,400 Added 17.18%
9,550 $131,000
Q4 2019

Feb 04, 2020

BUY
$15.02 - $20.57 $69,843 - $95,650
4,650 Added 132.86%
8,150 $131,000
Q2 2019

Aug 01, 2019

BUY
$17.37 - $26.27 $60,795 - $91,945
3,500 New
3,500 $0

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.